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There is considerable controversy regarding the role of T  cells in the regula- 
tion of immunogiobulin class switching. There is little question that B cells can 
switch Ig isotype in the absence of T  cells (1-3), and that these events can occur 
randomly (4) or according to gene order (5, 6). However, evidence is accumulat- 
ing to suggest that T  cells play an important role in this event. Immunization 
with various T-dependent antigens results in selective Ig class expression (7-9) 
and even isotype responses to thymus-independent antigens can be influenced 
by T  cells  (5,  6,  10-12).  However, T  cell regulatory influences in these cases 
may relate  to  a  nonswitching event,  i.e.,  expansion  of cells  precommitted to 
isotype. Such examples of T  cell expansion of isotype-committed B cells are well 
documented in both antigen-specific (13) and nonspecific systems (14). 
Direct  evidence  for  T  cell  regulation  of Ig  class  switching is  not  as  well 
documented. Two studies, one by Isakson et al. (15) and one by Kawanishi et 
al. (16),  provide the best evidence to date regarding the existence of "switch" 
T  cells.  Isakson  et  al.  (15)  demonstrated  a  B  cell  differentiation factor 
(BCDF)3  ,l  derived from a  murine T  cell clone that induces an increase in 3q 
secretion from lipopolysaccharide and BCDF-treated ~+ B cells.  Kawanishi and 
co-workers  (17)  described  a  T  cell  clone  derived  from  Peyer's  patches  that 
appears to direct surface IgM (sIgM)-bearing B cells to become sIgA  +.  In the 
latter case, no IgA secretion is noted unless a nonspecific terminal differentiation 
signal is added (17).  In both of these cases, however, it is unclear whether the 
target populations have not already undergone a  recombinational event in the 
Ig heavy chain gene, committing them to a given isotype. If this were the case, 
then the T  cells  described above would only be expanding an isotype-precom- 
mitted B cell population. This problem is difficult to resolve in view of the fact 
that heterogeneous B cell populations are used in these studies and the status of 
the constant region heavy chain (CH) gene has not been evaluated. 
In  the  present  study, the  malignant T  cells  derived from a  patient with a 
mycosis fungoides/Sezary's syndrome were found to promote nonspecific !g class 
switching from IgM to IgG and IgA. This was evident in several assay systems. 
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In addition,  and  as  further  evidence  that  these  malignant  cells were  switch  T 
cells,  the  switching  defect  in  a  patient  with  immunodeficiency and  hyper-IgM 
was corrected in vitro. 
Materials and  Methods 
Patient Material.  Heparinized blood was obtained from patient Rac, a patient with a 
mycosis fungoides/Sezary-like syndrome characterized by the presence of papular skin 
lesions with  Sezary cells noted on biopsy. There were no classical  Pautrier's abscesses 
present.  The patient's serum Ig profile consisted of an IgG of 2,480  mg%, an IgA of 
1,140 rag%, and no detectable IgM, as determined by standard radial immunodiffusion 
technique  (18).  A  bone  marrow aspirate  revealed  13%  plasma cells.  Of these,  ~50% 
contained IgG and 50% contained IgA. Very few IgM plasma cells were found. Peripheral 
blood  smears  revealed  10-30%  large  irregular  lymphoid  cells  with  lobulated  nuclei, 
consistent with Sezary cells. Results of immunofluorescent staining of cell surface markers 
on the patient's mononuclear cells (MNC) are listed in Table I. 
HIV  is  a  patient  with  acquired  immunodeficiency and  hyper-IgM as  described  by 
Cruchaud et al. (19).  The serum Ig profile consisted of absent IgG and IgA, with an IgM 
of 1,280 mg%. 
Cell  Separation  and  Culture  Conditions.  50  ml  of heparinized  venous  blood  were 
obtained  from  normal  laboratory volunteers  as  well  as  the  patients  described  above, 
diluted  1:3  with  sterile  phosphate-buffered saline  (PBS),  layered on  a  FicolI-Hypaque 
density gradient (Pharmacia Fine Chemicals, Piscataway, NJ), and centrifuged for 30 min 
at 500 g. The interface cells (MNC) were washed three times in PBS before use. Tonsillar 
MNC were obtained from routine tonsillectomy specimens, as previously described (14). 
T  and  B  cell  separation  was achieved  by a  rosetting  technique  using  neuraminidase- 
treated sheep red blood cells (SRBC) and FicoU-Hypaque density gradient centrifugation 
(14). 
All cells were cultured in RPMI 1640 (M. A. Bioproducts, Walkersville, MD), 10% fetal 
calf serum (Reheis Co., Inc., Phoenix, AZ), 1% penicillin, streptomycin (Gibco Laborato- 
ries, Grand Island, NY), and 2 mM glutamine (Gibco Laboratories), hereafter designated 
as complete culture  medium (CM).  In certain experiments, pokeweed mitogen (PWM) 
(1:100 dilution; Gibco Laboratories) was added. 
Isolation ofslgM ÷ Tonsillar B Cells.  Tonsiilar MNC were separated into T  and non-T 
fractions as described above. Interface cells were subjected to a second rosetting to remove 
contaminating T  cells (resultant populations <0.5%  OKT3+).  Non-T cells were washed 
three times in PBS and diluted in 5 mi of CM at a concentration of 4 x  106/ml. Ox RBC 
(ORBC) were coated with an F(ab')2 affinity-purified rabbit anti-human IgG or IgA, using 
a chromium chloride technique (20).  One ml of a 5% solution of the coated ORBC was 
added to the tonsilar non-T cells,  centrifuged at 200 g for 5 min, and incubated for 20 
min at 4°C.  The pellet was resuspended in CM, layered on a  Ficoli-Hypaque gradient, 
and centrifuged at 500 g  for 30 min at 4°C.  The interface cells were sIgM  ÷ with rare 
contaminating sIgG  + and sIgA  ÷ cells.  Immunofluorescent staining of these interface cells 
with  previously described  fluorescein-conjugated,  affinity-purified  F(ab')2 reagents  re- 
vealed the following: sIgM, 99%; sIgG, 0.3%; and sIgA, 0.01%. 
Isolation  of Tac  ÷ and  Tac-  cells.  The monoclonal antibody Tac (anti-TCGF [T cell 
growth factor] receptor) was kindly provided by Dr. Thomas Waldmann. To isolate the 
Tac  + cells from patient  Rac (30% of peripheral blood lymphocytes [PBL]), an indirect 
rosetting  technique  was performed using  F(ab')~ affinity-purified goat anti-mouse Ig- 
coated  ORBC  (14).  Resting T  cells  from  normal  controls  were  uniformly Tac- and, 
therefore,  no isolation was performed on these populations.  40  million TRac cells were 
incubated with Tac antibody (1:40,000 dilution of original ascites in CM) for 30 rain at 
22°C. Cells were washed three times in CM and resuspended in 0.5 ml CM. 0.5 ml of a 
2% Ig-coated ORBC solution was added and the mixture was kept on ice for 5 rain. The 
cells were then spun at 200 g for 5 min at 4°C and further incubated on ice for 30 min. 
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resultant  pellet  (Tac  ÷ cells)  was  subjected  to  hypotonic lysis with  0.84%  ammonium 
chloride for 5 min on ice. The interface cells were Tac- (<1% staining with Tac). 
lmmunofluorescence.  Standard direct and indirect immunofluorescence was performed 
as previously described (21).  A cytofluorograph (30-H; Ortho Diagnostic Systems,  Inc., 
Westwood, MA) was used for all fluorescence analysis. OKT3, OKT4, OKT8, and OKM 1 
were obtained from Ortho Diagnostic, Raritan, NJ. 
Plaque Assay.  A reverse hemolytic assay using protein A-coated SRBC was performed 
as previously described (22). Affinity-purified rabbit anti-human IgG, IgA, and IgM were 
obtained from Cappel  Laboratories, Cochranville,  PA and  used at a  1:100 dilution as 
developing antisera.  All cultures were assayed on day 6  unless  otherwise indicated.  In 
some experiments, T  cells were irradiated (1,500 rad) using a cesium source (Isomedix, 
Inc., Whippany, N  J), before addition to culture. 
Results 
Characteristics  of MNC,  T Cells and B CeUs from Patient Rac.  The peripheral 
blood of this patient contained a  malignant clone of T  cells that accounted for 
approximately  one-third  of  the  MNC.  This  was  especially  evident  from  the 
blastoid appearance of these cells and the presence of the Tac antigen on their 
membrane (Table I). This picture was similar to that often observed in the type 
of Sezary cell disease with primary cutaneous manifestations of mycosis fungoides. 
The Tac positivity permitted isolation of these cells from the peripheral blood. 
Table I summarizes the results of cell surface staining using various monoclonal 
antibodies and  F(ab')2 affinity-purified rabbit  anti-human  IgG,  IgA, IgM, and 
IgD. Other than the Tac positivity noted above, results were unremarkable. 
Ig analysis of the serum  of this patient showed a  selective depletion of IgM. 
Experiments  were  therefore  initiated  to  determine  where  the  defect  in  IgM 
production  existed.  As  seen  in  Table  II  (one  representative  experiment  in  a 
series of four), no IgM plaque-forming cells (PFC) were noted when MNC-Rac 
were  cultured  in  the  presence of PWM,  whereas  IgG and  IgA PFC, although 
consistently lower than  the normal control, were present.  Co-culture of non-T 
TABLE  I 
Cell Surface Staining 
Rac-MNC  T=c*  HIV-MNC 
%  %  % 
OKT3*  66.0  98.3  68.0 
OKT4  42.0  __a  39.5 
OKT8  19.4  --  22.4 
K/~,  6.9  0.4  8.6 
OKM1  12.9  2.6  10.2 
slgG  +  2.0  --  <0.5 
sIgA  +  0.9  --  <0.5 
slgM  ÷  0.4  I  3.6 
slgD  +  0.5  --  -- 
Tac  --  30.2  -- 
la  --  24.6 (weak)  -- 
* Isolated T cells from Rac-MNC. 
* 2 x  10  s peripheral blood MNC or T cells from patient Rac or HIV were 
stained by direct  or indirect immunofluorescence (see Materials and 
Methods). Results are expressed as percent positivity. 
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TABLE  II 
Characteristics ofUnseparatedMNC, T Cells, and B CeUsfrom Patent 
Rac 
Target  Added cells  PWM 
PFC/welI* 
G  A  M 
MNC Rac  -  -  0  80  0 
Rac  -  +  740  600  0 
Control  -  -  50  20  90 
Control  -  +  12,090  880  6,760 
Non-T Rac  -  +  0  40  0 
T~¢  +  2,460  560  0 
Tcom~l  +  3,130  860  0 
Non-T control  -  +  220  90  120 
T=c  +  5,010  1,420  10 
Tco.t~l  +  15,000  510  2,190 
* One million MNC were cultured with or without PWM or 1 x  10  8 non-T cells 
were co-cultured with or without allogeneic T  cells (I  x  10  6) in the presence 
of PWM.  A  reverse hemolytic plaque assay was performed  on day  6,  using 
class-specific developing antisera. 
cells from patient  Rac with either autologous or ailogeneic control T  cells and 
PWM yielded similar results, with no IgM PFC but good IgG and IgA responses. 
The addition of Epstein-Barr virus (EBV) to Rac non-T cells however, did result 
in  the  production  of some  IgM  PFC,  indicating  that  the  cellular  machinery 
necessary for IgM production and secretion was still  present in some cells (data 
not shown). 
Experiments were performed to determine whether the T  cells from Rac (Trac) 
were playing  a  role  in  the  diminished  IgM  production.  Co-culture  of control 
non-T cells with Trac and PWM resulted in a marked absence of IgM PFC (Table 
II), whereas IgA production was unchanged and IgG was only slightly decreased, 
or unchanged,  when compared with control autologous T  cells. To determine 
whether this finding was due to IgM class-specific suppression, two assay systems 
were used. In the firsL  1 x  106 allogenic MNC and PWM were cultured with  1 
X  106  Trac or normal  allogeneic  T  cells.  No suppression  was noted  of any  Ig 
class, either with irradiated or unirradiated Trac or two allogeneic control T  cell 
populations (Table III). In the second system, irradiated or unirradiated  T~ac or 
control T  cells were added to three different iymphoblastoid B cells lines, SeD 
(IgM,  r),  8866P  (IgG,  K), and  32al  (IgA,  ~,) and  tested  for suppression  of Ig 
secretion.  1  ×  105 T~ac or control  T  cells were added  to  1 ×  10 4  or  1  X  10 5 
lymphoblastoid cells, and class-specific Ig secretion was measured at  12, 24, 48, 
72, and 96 h.  No suppression was seen with Tr~c or control T  cells when added 
to either  8866P or  32A1  (data not shown).  Suppression  (30-50%)  was noted, 
however,  when  T  cells were co-cultured  with  SeD,  but  this  response was not 
specific for T~c. In fact, T=c exhibited the least suppression of the three T  cell 
populations used, at any time tested (data not shown). Thus, since the mechanism 
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TABLE  Ill 
Lack of lgM Suppression by T,ac Cells 
Target  Allogeneic  cells 
PFC/well* 
G  A  M 
MNC control  --  9,260  8,110  4,200 
T~  12,560  7,650  4,490 
Tb  8,770  5,490  3,550 
Tr~  11,680  6,820  3,860 
Ta-x*  10,660  4,980  6,090 
Tb-x  9,880  4,600  5,600 
T,~c-x  8,600  2,120  2,900 
* As  per  Table  II.  One  million  MNC  were  co-cultured  with  1  x  106 
allogeneic T  cells in the presence of PWM (1:100 dilution). 
* Irradiated (1,500 rad). 
suppression, experiments were performed to determine whether Trac was induc- 
ing a class switch. 
Ability  of Trac to Induce a Class Switch from IgM to IgG and IgA.  A  model for 
the assay of T  cell regulation of Ig class switching was established as follows. 
sIgM  +  tonsillar  B  cells  were  used  (see  Materials  and  Methods).  These  were 
depleted of significant sIgG and sIgA by a direct rosetting technique. IgG and 
IgA produced after stimulation with T  cells was considered evidence suggestive 
of a class switch, since cells definitively committed to other isotypes were already 
depleted. 
One million #+ tonsillar B cells were co-cultured with  1 ×  106 T~ac or one of 
two different ailogeneic T cell controls and PWM. In three separate experiments 
(Table IV), the addition of allogeneic T  cells to the tt  + tonsillar B cells resulted 
in the production of increased IgM PFC (range, 5,620-9,870).  In addition, IgG 
and IgA production was also noted (range, 1,760-7,690 and 880-6,400, respec- 
tively), although generally lower than that seen with unfractionated B cells (Table 
IV legend and data not shown). However, addition of T~ac cells to the tt  + tonsillar 
B cells resulted in little or no IgM PFC (range, 0-220) but induction of IgG and 
IgA PFC (range, 650-1,000  and 220-2,000,  respectively) was still  noted. The 
number of IgG and IgA PFC never achieved the levels seen with normal control 
T  cells but they were always significantly higher than the number of IgM PFC. 
Evidence that the Tac  + Trac Cells Are Important in the Switching Process.  Trac  cells 
were depleted of the 30% Tac  + cells by indirect rosetting technique (see Materials 
and Methods). The resulting Tac- population was no longer capable of inducing 
an Ig class switch (Table V; one representative experiment of three with non-T 
cells) (5,580  vs.  40  PFC and 290 vs.  0  PFC for IgG and IgA, respectively). In 
contrast, the directly isolated Tac  + cells did induce IgG and IgA PFC (5,580 vs. 
2,080 PFC and 290 vs.  190 PFC for IgG and IgA, respectively). 
Unfractionated Trac cells gave rise to higher numbers of IgG and IgA PFC, 
suggesting  the  necessity  for  additional  helper  T  cells  in  the  differentiation 
process. The addition of Tac antibody to the cultures (1:40,000 dilution at the 
concentration  used  for  rosetting)  (Table  V)  or  a  range  of  concentrations 
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TABLE  IV 
Tr.c Induces an Ig Class Switch in # + Tonsillar B Cells 
Exp.  Added cells 
PFC/welI* 
G  A  M 
1' 
--  0  0  10 
Ta  5,000  6,400  8,000 
Tb  7,690  3,400  5,900 
T~,  1,000  2,000  220 
--  0  0  40 
T~  4,290  2,860  9,870 
Ta  2,650  1,760  5,620 
T~c  880  420  0 
--  0  0  90 
Tb  6,730  1,340  8,320 
Tc  1,760  880  7,810 
T~,  650  220  10 
* As per Table I1. All cultures performed in the presence of PWM. 
* #+ tonsillar B cells were selected as described in Materials and Methods. 
In experiment 1, co-culture of Ta with unseparated tonsil B cells in the 
presence of PWM resulted in  12,860, 9,870, and 12,990 PFC for IgG, 
IgA, and  IgM,  respectively. Tb and tonsil B  cells resulted in  16,980, 
7,630, and 12,230 PFC for G, A, and M, respectively. T,~c and tonsil B 
cells resulted in 2,340, 1,890, and 10 PFC for G, A, and M, respectively. 
Results in the other experiments were similar. 
TABLE  V 
Role of Tac + T Cells in the Switching Process 
139 
Target cells  Added cells 
PFC/well* 
G  A  M 
Peripheral blood non-T  --  70  20  110 
Tauto~,.s  8,870  980  5,460 
T=,:  5,580  290  90 
T,~c minus Tac  + cells*  40  0  20 
Tac  + T  cells  2,080  190  30 
Tac antibody (1:40,000)  30  0  10 
* As per Table 11. All cultures performed in the presence of PWM. 
* Tac + cells were isolated by an indirect rosetting technique as described in Materials and Methods. 
or isotype expression. Since there are no resting Tac  ÷ T  cells in normal  MNC, 
control depletion of Tac + cells could not be performed. 
Trac Induces  a  Class Switch in  Cells from  a Patient  With Immunodeficiency  and 
Hyper-lgM.  Since #+ tonsilar B cells may already be committed to other isotypes 
at the DNA level but not yet express sIgG or sIgA, it was necessary to find a 
better model system for Ig class switching. Immunodeficiency with hyper-IgM is 
a syndrome characterized by normal to elevated levels of IgM with undetectable 
IgG and  IgA  (19,  23,  24).  Previous attempts  (25-26)  to induce  IgG and  IgA 
secretion in cells from these patients in vitro have been unsuccessful using various 
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TABLE  VI 
7",=+ Induces an Ig Class Switch in Celts from a Patient (HIV) with the 
Hyper-IgM Syndrome 
Target cells  Added cells 
PFC/well* 
G  A  M 
HIV MNC  --  0  0  5,690 
T,:o.t,-ol  0  0  8,750 
T,-.c  550  0  0 
HIV non-T  --  0  0  110 
T .... i  0  0  15,980 
T~.  230  0  10 
T=.m=ogo.,  0  0  9,770 
* As per Table  II. All cultures performed in the presence of PWM. T,~c 
or Tco,t~l cells in the presence of PWM did not secrete any Ig in several 
experiments. 
this syndrome represents an intrinsic  B cell defect, the possibility remains that, 
in certain  patients,  there is a  defect in switch signals from T  cells. To address 
this possibility, 1 ×  106 T~ac or other allogeneic T  cells were added to either 1 x 
10  ~ MNC or non-T cells from patient HIV (Table VI), with immunodeficiency 
and hyper-IgM. As seen in Table VI,  1 ×  106 HIV-MNC stimulated with PWM 
yielded 5,690 IgM PFC but no IgG or IgA PFC. Addition of allogeneic control 
T  cells resulted in a slight increase in IgM PFC (8,750 PFC/culture) but still  no 
IgG or IgA PFC.  However, when Trac  cells were added, no IgM PFC and  550 
IgG  PFC  were noted.  Similar  data were obtained  using non-T  cells from  this 
patient  (Table  VI).  T~,c or allogeneic  T  cells alone  in  the  presence  of PWM 
yielded no PFC response in numerous experiments (Table VI, legend). 
Discussion 
We have demonstrated the existence of a T  cell (T~ac) derived from a patient 
with a mycosis fungoides/Sezary's syndrome, which is capable of inducing an Ig 
class switch from  IgM to IgG and  IgA.  The evidence for this comes from two 
different assay systems.  Negatively selected #+  tonsillar  B  cells were  used as a 
model for Ig switching. In the absence of T  cells and mitogen, IgG and IgA PFC 
are not demonstrable (Table IV). However, when Tr,  c cells were added, IgG and 
IgA PFC were noted, with little or no IgM secretion. Since our data show that 
IgM production was not actively suppressed by Tr,~ (Table III), these cells appear 
to be inducing a nonspecific Ig class switch. This does not address the issue that 
sIgM + B cells might already be committed to other isotypes at the DNA level. It 
is still  possible that Trac cells might be expanding populations of IgG- and IgA- 
committed cells. Indeed, control allogeneic T  cells were also capable of inducing 
IgG and  IgA PFC in this system, although,  in contrast to T ....  significant  IgM 
PFC  were also  noted  (Table  IV).  Therefore,  on  the  basis of the  above data, 
either switch T  cells are present in small numbers in the normal T cell population, 
with effects amplified by the large numbers of other T  cells secreting various B 
cell growth and differentiation factors, or the #+ tonsillar B cell assay only depicts 
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This same problem has plagued the other studies (15-17) that described switch 
T cells or factors and where mitogen-stimulated heterogeneous B cell populations 
were used. To resolve this issue, a source of B cells without any evidence of Ig 
gene rearrangement must be used as the target population. To this end we have 
obtained cells from a  patient  with  immunodeficiency and  hyper-IgM.  As  de- 
scribed by Cruchaud et al. (19), this syndrome is characterized by absent serum 
IgG and IgA with normal to high levels of serum IgM. In vitro studies (25-26) 
performed with B cells from these patients confirmed the lack of IgG and IgA 
secretion, using various stimuli including normal allogeneic T  cells. In addition, 
the genes encoding for the C, region have been found to be in the germline 
configuration (S.  P.  Kwan and F.  Rosen, personal  communication; in  various 
patients including HIV). Thus B cells from these patients appear to meet the 
criteria for a  model of T  cell influence in the regulation of Ig class  switching, 
and should help resolve whether Trac effects a class switch. The data in Table VI 
suggest that this indeed is the case. Co-culture of normal allogeneic T  cells and 
PWM,  or PWM alone, with peripheral blood MNC or B cells derived from a 
patient with  immunodeficiency and hyper-IgM, resulted only in  an  IgM  PFC 
response (Table VI). These data are consistent with other in vitro studies in these 
patients (25-26).  When T~,c cells and PWM are co-cultured with these same B 
cells, however, IgG PFC are noted, with a concomitant decrease in IgM secretion. 
These findings are not confined to the one patient (HIV) described here, as we 
have now screened several other patients with this disorder who are capable of 
secreting IgG and/or IgA in the presence of T~ac cells (Mayer, Kwan, Thompson, 
Chiorazzi,  Rosen, and Kunkel, manuscript in preparation).  This suggests that 
there may be a defect, at least with some patients with this syndrome, in "switch" 
T  cells. The fact that normal T  cells are unable to correct this defect, as shown 
here and as previously documented (26), might reflect quantitative differences 
in switch signals elaborated by normal and Tr~¢ cells. Alternatively, it may reflect 
the lack of an appropriate activation stimulus in the normal T  cell population. 
Tra~ cells appear to be a malignant expansion of in vivo activated switch T  cells, 
as evidenced by the finding that the Tac  ÷ Tr~c cells appear to be responsible for 
the switch-inducing activity (Table V) and by the Tac  + malignant cells on the 
skin biopsy of patient Rac (data not shown). 
The activation signal for the switch T  cells is unknown but it might relate to 
some T-dependent antigens known to enhance non-u Ig responses (7-9).  PWM 
does not appear to provide an optimal stimulus for Ig class  switching (27-28), 
although some low-level switching might still occur. This might explain, in part, 
why normal T  cells in the presence of PWM are unable to induce an Ig class 
switch  in  B  cells  from  patients  with  the  hyper-IgM syndrome.  It  might  also 
explain why T  cells from patients with this syndrome function normally in B cell 
differentiation assays, (26). Although these patients may have a defect in switch 
T  cells, other T  cell functions, such as secretion of B cell growth and differentia- 
tion factors, are presumably intact. Thus, co-culture of hyper-IgM T  cells with 
IgG- and IgA-committed B cells would result in IgG and IgA secretion, respec- 
tively. 
The mechanism by which T,.,c cells induce an Ig class  switch is unclear. It is 
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However, supernatants  from lectin-stimulated  T~ac cells or from a  Tac +,  IL-2- 
dependent T~c cloned cell line (active in inducing an Ig class switch) have failed 
to induce switching. These supernatants are also deficient in nonspecific BCDF 
or BCGF, which may account for the relatively low levels of IgG and IgA PFC 
seen in our experiments. Thus, the presence of Trac cells appears to be necessary 
for actual  switching to occur, although  we cannot  rule out the possibility that 
switch factors are present  in  concentrations  too low to have any effect in  our 
assay systems.  The  presence  of both  IgG and  IgA  PFC suggests that  the  T=c 
signal might  mediate an early, nonspecific event, shutting off #  or 6 secretion, 
and allowing for other switch signals to act more specifically. This is supported 
by the finding that sIgD is rapidly lost from the B cell surface within  12 h of co- 
culture with T~c (Mayer, Kwan et al., manuscript in preparation). 
The accumulated evidence suggests that there is a T  cell capable of regulating 
Ig class switching. Whether this malignant clone of T  cells is a part of the normal 
physiologic process (part of a series of switch T  cells) is currently being investi- 
gated. The finding of a reversal of a switching defect in patients with immuno- 
deficiency and hyper-IgM suggests that this may be so. 
Summary 
Evidence is presented  for the  existence of a  "switch"  T  cell derived from a 
patient with mycosis fungoides/Sezary's syndrome. The serum immunoglobulin 
profile  in  this  patient  revealed  high  IgG  and  IgA  but  no  detectable  IgM. 
Peripheral blood mononuclear cells from this patient secreted only IgG and IgA 
in  the  presence  of pokeweed mitogen.  T  cells (T~ac) co-cultured  with  normal 
allogeneic non-T cells and pokeweed mitogen resulted in only IgG and IgA PFC, 
with little or no IgM secretion. There was no evidence of active suppression of 
IgM.  Rather,  these T  cells appeared to induce an  Ig class switch from IgM to 
IgG and  IgA,  when co-cultured with #+ tonsillar  B cells.  Further evidence was 
obtained using mononuclear cells derived from a patient with immunodeficiency 
and hyper-IgM, a  syndrome characterized  by a  lack of IgG and IgA secretion. 
The addition of Tr,c cells to either peripheral  blood mononuclear cells or non- 
T  cells from a  patient  with  hyper-IgM  syndrome resulted  in  new secretion of 
IgG, with a concomitant decrease in IgM secretion, whereas control T  cells were 
not effective in inducing secretion of any isotype other than IgM. Isolated Tac  ÷ 
T  cells from Tr,c appear to be responsible for this effect. 
We wish to thank Christopher Thompson for his invaluable technical assistance, Pamela 
Bolton  for help in preparing this manuscript,  and Dr.  Nicholas Chiorazzi  for supplying 
cells from patient HIV. 
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